Eugenio Cammilluzzi

Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide

Paola Papaldo, Massimo Lopez, Enrico Cortesi et al. · Journal of Clinical Oncology · 2003 · 75 citations

Medicine, Oncology, Pharmacology +16

Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: Results of an Experts Panel Meeting

Cesare Gridelli, Paolo Maione, D. Amoroso et al. · Critical Reviews in Oncology/Hematology · 2007 · 47 citations

Medicine, Dermatology, Oncology +17

Whole-breast irradiation: a subgroup analysis of criteria to stratify for prone position treatment

Sara Ramella, Lucio Trodella, Edy Ippolito et al. · Medical dosimetry · 2011 · 18 citations

Medicine, Oncology, Radiation Oncology +15

Erlotinib and Concurrent Chemoradiation in Pretreated NSCLC Patients: Radiobiological Basis and Clinical Results

Sara Ramella, Antonio Alberti, Eugenio Cammilluzzi et al. · BioMed Research International · 2013 · 16 citations · Full text

Medicine, Oncology, Radiation Oncology +17